Home Cart Sign in  
Chemical Structure| 68162-47-0 Chemical Structure| 68162-47-0
Chemical Structure| 68162-47-0

*Storage: Inert atmosphere,2-8°C.

*Shipping: Normal

(4-(Bromomethyl)phenyl)boronic acid

CAS No.: 68162-47-0

4.5 *For Research Use Only !

Cat. No.: A154746 Purity: 98%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
1g łÇʶÊÊ In Stock In Stock Login
5g łËÿ¶ÊÊ In Stock In Stock Login
10g ł§ÿ¶ÊÊ In Stock In Stock Login
25g łďď¶ÊÊ Inquiry In Stock Login

Please Login or Create an Account to: See VIP prices and availability

  • 1g

    łÇʶÊÊ

  • 5g

    łËÿ¶ÊÊ

  • 10g

    ł§ÿ¶ÊÊ

  • 25g

    łďď¶ÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of [ 68162-47-0 ]

CAS No. :68162-47-0
Formula : C7H8BBrO2
Linear Structure Formula :(HO)2BC6H4CH2Br
M.W : 214.85
SMILES Code : BrCC1=CC=C(C=C1)B(O)O
MDL No. :MFCD01318113
InChI Key :PDNOURKEZJZJNZ-UHFFFAOYSA-N
Pubchem ID :2735593

Safety of [ 68162-47-0 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H314
Precautionary Statements:P260-P264-P270-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P405-P501
Class:8
UN#:3261
Packing Group:

Calculated chemistry of [ 68162-47-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 11
Num. arom. heavy atoms 6
Fraction Csp3 0.14
Num. rotatable bonds 2
Num. H-bond acceptors 2.0
Num. H-bond donors 2.0
Molar Refractivity 49.1
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

40.46 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.0
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.38
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.11
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.1
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.25
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.57

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.31
Solubility 1.04 mg/ml ; 0.00486 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-1.83
Solubility 3.16 mg/ml ; 0.0147 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.55
Solubility 0.603 mg/ml ; 0.00281 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.63 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.95

Application In Synthesis [ 68162-47-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 68162-47-0 ]

[ 68162-47-0 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 68162-47-0 ]
  • [ 939-69-5 ]
  • [ 1421277-81-7 ]
  • 2
  • potassium hydrogen difluoride [ No CAS ]
  • [ 68162-47-0 ]
  • [ 125414-41-7 ]
  • C17H19B2F6NO2(2-)*2K(1+) [ No CAS ]
YieldReaction ConditionsOperation in experiment
Compound 20: A solution of <strong>[125414-41-7]N-Boc-serinol</strong> (357 mg, 1.88 mmol, Aldrich, 661074) in THF (5 mL) is added drop wise over 5 minutes to a suspension of NaH (150 mg, 3.75 mmol, 60% dispersion in mineral oil) in anhydrous THF (5 mL). The reaction mixture is stirred at RT for 2 h, then a solution of 4-(bromomethyl)phenylboronic acid (802 mg, 3.75 mmol, Aldrich, 679437) in THF (10 mL) is added. The reaction mixture is stirred for another 10 hrs. The solvent is then removed in vacuo, and 5 mL of ice cold 80% TFA in water is added to the residue slowly. After stirring at RT for 15 minutes, the reaction mixture is neutralized with 1M NaOH solution, treated with a solution of KHF2 in water-methanol, and then stirred for another hour. Purification of the product is achieved by a C18 column (acetonitrile-water). The identity of the product is confirmed by MS and NMR.
 

Related Products

Technical Information

Categories

Related Functional Groups of
[ 68162-47-0 ]

Organoboron

Chemical Structure| 51323-43-4

A177091 [51323-43-4]

3-Bromomethylphenylboronic acid

Similarity: 0.98

Chemical Structure| 91983-14-1

A113992 [91983-14-1]

2-Bromomethylphenylboronic acid

Similarity: 0.90

Chemical Structure| 17933-03-8

A156561 [17933-03-8]

m-Tolylboronic acid

Similarity: 0.82

Chemical Structure| 172975-69-8

A119477 [172975-69-8]

3,5-Dimethylphenylboronic acid

Similarity: 0.80

Chemical Structure| 55499-44-0

A165802 [55499-44-0]

2,4-Dimethylphenylboronic acid

Similarity: 0.80

Aryls

Chemical Structure| 51323-43-4

A177091 [51323-43-4]

3-Bromomethylphenylboronic acid

Similarity: 0.98

Chemical Structure| 91983-14-1

A113992 [91983-14-1]

2-Bromomethylphenylboronic acid

Similarity: 0.90

Chemical Structure| 17933-03-8

A156561 [17933-03-8]

m-Tolylboronic acid

Similarity: 0.82

Chemical Structure| 172975-69-8

A119477 [172975-69-8]

3,5-Dimethylphenylboronic acid

Similarity: 0.80

Chemical Structure| 55499-44-0

A165802 [55499-44-0]

2,4-Dimethylphenylboronic acid

Similarity: 0.80

Bromides

Chemical Structure| 51323-43-4

A177091 [51323-43-4]

3-Bromomethylphenylboronic acid

Similarity: 0.98

Chemical Structure| 91983-14-1

A113992 [91983-14-1]

2-Bromomethylphenylboronic acid

Similarity: 0.90

Chemical Structure| 1259318-83-6

A120328 [1259318-83-6]

(3-Bromo-2,5-dimethylphenyl)boronic acid

Similarity: 0.80

Chemical Structure| 221006-71-9

A472333 [221006-71-9]

(4-Bromo-2-methylphenyl)boronic acid

Similarity: 0.79

Chemical Structure| 849062-36-8

A621328 [849062-36-8]

(3-Bromo-5-methylphenyl)boronic acid

Similarity: 0.79

Benzyl Bromides

Chemical Structure| 51323-43-4

A177091 [51323-43-4]

3-Bromomethylphenylboronic acid

Similarity: 0.98

Chemical Structure| 91983-14-1

A113992 [91983-14-1]

2-Bromomethylphenylboronic acid

Similarity: 0.90

Chemical Structure| 138500-85-3

A207813 [138500-85-3]

2-(4-(Bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.70

Chemical Structure| 377780-72-8

A119114 [377780-72-8]

2-(2-(Bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.68

Chemical Structure| 1150271-74-1

A152680 [1150271-74-1]

2-(4-(Bromomethyl)-3-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.56